Prothena Corp Public (PRTA) Non-Current Deferred Tax Liability (2013)

Prothena Corp Public (PRTA) posted quarterly Non-Current Deferred Tax Liability of $201000.0 for Q2 2013.

Prothena Corp Public (PRTA) Non-Current Deferred Tax Liability (2013) Analysis & Trends

Prothena Corp Public's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $201000.0 for Q2 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Prothena Corp Public	458.45 Mn	170.25 Mn	-

Download Data

Date	Value
Jun 30, 2013	201,000.00
Jun 30, 2013	201,000.00